Zhong‐Wu Lu

1.5k total citations
39 papers, 714 citations indexed

About

Zhong‐Wu Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, Zhong‐Wu Lu has authored 39 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Oncology and 12 papers in Surgery. Recurrent topics in Zhong‐Wu Lu's work include Thyroid Cancer Diagnosis and Treatment (22 papers), BRCA gene mutations in cancer (6 papers) and Thyroid and Parathyroid Surgery (5 papers). Zhong‐Wu Lu is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (22 papers), BRCA gene mutations in cancer (6 papers) and Thyroid and Parathyroid Surgery (5 papers). Zhong‐Wu Lu collaborates with scholars based in China, United States and Hong Kong. Zhong‐Wu Lu's co-authors include Qinghai Ji, Ben Ma, Yulong Wang, Wenjun Wei, Tian Liao, Shuwen Yang, Duo Wen, Yu Wang, Li Zhou and Ning Qu and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Zhong‐Wu Lu

39 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhong‐Wu Lu China 17 255 243 232 191 134 39 714
Krzysztof Kuzdak Poland 15 225 0.9× 233 1.0× 134 0.6× 195 1.0× 153 1.1× 72 630
King F. Kwong United States 16 51 0.2× 212 0.9× 112 0.5× 191 1.0× 74 0.6× 27 751
Salvatore Fricano Italy 12 148 0.6× 227 0.9× 102 0.4× 56 0.3× 148 1.1× 19 459
Patsy S. Soon Australia 16 256 1.0× 516 2.1× 158 0.7× 289 1.5× 511 3.8× 32 909
Zhili Yang China 15 108 0.4× 200 0.8× 138 0.6× 300 1.6× 204 1.5× 36 648
Seiichiro Ishii Japan 10 232 0.9× 586 2.4× 122 0.5× 77 0.4× 39 0.3× 14 787
Osama Hussein Egypt 14 44 0.2× 219 0.9× 150 0.6× 129 0.7× 75 0.6× 39 483
Tricia A. Moo‐Young United States 15 326 1.3× 277 1.1× 227 1.0× 79 0.4× 66 0.5× 34 687
Cristina Álvarez‐Escolá Spain 14 552 2.2× 325 1.3× 128 0.6× 112 0.6× 32 0.2× 67 801
Roberto A. Lima Brazil 16 71 0.3× 824 3.4× 641 2.8× 90 0.5× 79 0.6× 36 1.2k

Countries citing papers authored by Zhong‐Wu Lu

Since Specialization
Citations

This map shows the geographic impact of Zhong‐Wu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong‐Wu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong‐Wu Lu more than expected).

Fields of papers citing papers by Zhong‐Wu Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong‐Wu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong‐Wu Lu. The network helps show where Zhong‐Wu Lu may publish in the future.

Co-authorship network of co-authors of Zhong‐Wu Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong‐Wu Lu. A scholar is included among the top collaborators of Zhong‐Wu Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong‐Wu Lu. Zhong‐Wu Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiaying, Naisi Huang, Wenjun Wei, et al.. (2023). The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study. Annals of Surgical Oncology. 30(12). 7172–7180. 17 indexed citations
2.
Huang, Naisi, Jiaying Chen, Ben Ma, et al.. (2023). A multicenter prospective study of lateral neck lymph node mapping in papillary thyroid cancer. Gland Surgery. 12(11). 1500–1507. 2 indexed citations
3.
Lu, Zhong‐Wu, et al.. (2022). Feasibility of 1-Ethyl-4-butyl-1,2,4-triazolium Acetyl Amino Acid Ionic Liquids as Sustainable Heat-Transfer Fluids. ACS Sustainable Chemistry & Engineering. 10(11). 3417–3429. 9 indexed citations
4.
Han, Paul K. J., Licheng Tan, Pengcheng Yu, et al.. (2022). Development and validation of a gene model predicting lymph node metastasis and prognosis of oral squamous cell carcinoma based on single‐cell and bulk RNA ‐seq analysis. Journal of Oral Pathology and Medicine. 52(5). 389–401. 3 indexed citations
5.
Xu, Weibo, Cuiwei Li, Ben Ma, et al.. (2021). Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer. Frontiers in Oncology. 11. 641851–641851. 5 indexed citations
6.
Huang, Naisi, Pengcheng Yu, Paul K. J. Han, et al.. (2021). Different clinicopathologic features predispose to different patterns of distant metastasis with heterogeneous short‐term prognosis in patients with differentiated thyroid cancer. Clinical Endocrinology. 96(3). 402–412. 7 indexed citations
7.
Huang, Naisi, Wenjun Wei, Jun Xiang, et al.. (2021). The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial. Thyroid. 31(12). 1808–1813. 41 indexed citations
8.
Hu, Jia‐Qian, Duo Wen, Ben Ma, et al.. (2020). IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro. Journal of Cancer. 11(14). 4250–4260. 17 indexed citations
9.
Jiang, Hongyi, Ben Ma, Weibo Xu, et al.. (2020). A Novel Three-lncRNA Signature Predicts the Overall Survival of HNSCC Patients. Annals of Surgical Oncology. 28(6). 3396–3406. 14 indexed citations
10.
Wei, Wenjun, Jia‐Qian Hu, Duo Wen, et al.. (2020). Apoptosis Activation in Thyroid Cancer Cells by Jatrorrhizine-Platinum(II) Complex via Downregulation of PI3K/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Medical Science Monitor. 26. e922518–e922518. 7 indexed citations
11.
Huang, Naisi, Zhong‐Wu Lu, Qing Guan, et al.. (2020). Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion. Oral Oncology. 115. 105092–105092. 7 indexed citations
12.
Ma, Ben, Hongyi Jiang, Duo Wen, et al.. (2019). Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 104(9). 3713–3725. 32 indexed citations
13.
Han, Litao, Jia‐Qian Hu, Ben Ma, et al.. (2019). IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis. Diagnostic Pathology. 14(1). 52–52. 17 indexed citations
14.
Hu, Jia‐Qian, Pengcheng Yu, Yulong Wang, et al.. (2019). Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer. European Archives of Oto-Rhino-Laryngology. 276(12). 3425–3434. 10 indexed citations
15.
Zhu, Mingyu, Xin Liu, Yuan Qu, et al.. (2019). Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis. Journal of bone oncology. 15. 100219–100219. 20 indexed citations
16.
Ma, Ben, Weibo Xu, Wenjun Wei, et al.. (2018). Clinicopathological and Survival Outcomes of Well-Differentiated Thyroid Carcinoma Undergoing Dedifferentiation: A Retrospective Study from FUSCC. International Journal of Endocrinology. 2018. 1–11. 17 indexed citations
17.
Ma, Ben, Qing Guan, Yunjun Wang, et al.. (2018). Lateral cervical lymph node mapping in papillary thyroid carcinoma: a prospective cohort study. 45(20). 1053–1056. 1 indexed citations
18.
19.
Yang, Shuwen, Li Zhou, Zhong‐Wu Lu, et al.. (2017). Systematic review with meta-analysis of intraoperative neuromonitoring during thyroidectomy. International Journal of Surgery. 39. 104–113. 105 indexed citations
20.
Sun, Guohua, Yu Wang, Yongxue Zhu, et al.. (2012). Lymph node metastasis between sternocleidomastoid and sternohyoid muscle in clinically node‐positive papillary thyroid carcinoma. Head & Neck. 35(8). 1168–1170. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krzysztof Kuzdak Breakdown of academic impact, for papers by King F. Kwong Breakdown of academic impact, for papers by Salvatore Fricano Breakdown of academic impact, for papers by Patsy S. Soon Breakdown of academic impact, for papers by Zhili Yang Breakdown of academic impact, for papers by Seiichiro Ishii Breakdown of academic impact, for papers by Osama Hussein Breakdown of academic impact, for papers by Tricia A. Moo‐Young Breakdown of academic impact, for papers by Cristina Álvarez‐Escolá Breakdown of academic impact, for papers by Roberto A. Lima
Rankless by CCL
2026